Cardioneuroablation as a Therapeutic Approach for Functional AV Block Presenting Late After AVNRT Ablation
Rodolfo San Antonio1,2, Andrea Di Marco1,2, Jordi Mercé1,2
1Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain.
Cardioneuroablation (CNA) offers a promising alternative to pacemakers for late-onset atrioventricular block (AVB) after tachycardia ablation. This study shows CNA effectively managed AVB symptoms in three patients, preventing syncope recurrence.
Area of Science:
- Electrophysiology
- Cardiac Arrhythmia Management
- Interventional Cardiology
Background:
- Atrioventricular block (AVB) is a rare but serious complication after atrioventricular nodal reentrant tachycardia (AVNRT) ablation.
- Patients undergoing AVNRT ablation face an increased risk of late-onset AVB and pacemaker implantation.
- Cardioneuroablation (CNA) is a potential alternative for syncope and conduction disorders, but its role in post-AVNRT AVB is unestablished.
Purpose of the Study:
- To evaluate the efficacy of Cardioneuroablation (CNA) in managing late-onset paroxysmal atrioventricular block (AVB) after successful AVNRT ablation.
- To assess CNA as an alternative to pacemaker implantation in this specific patient cohort.
- To investigate the procedural and clinical outcomes of CNA targeting specific ganglionated plexuses.
Main Methods:
- Prospective study of three patients with syncope due to late-onset AVB post-AVNRT ablation.
- Assessment of infrahisian and suprahisian conduction using atropine testing.
- Biatrial CNA performed using Ensite X EP System, targeting inferior paraseptal and left superior ganglionated plexuses with radiofrequency energy.
- Success defined by abolition of atropine response, no syncope recurrence, and normal conduction on Holter monitoring.
Main Results:
- Acute procedural success achieved in all three patients, with reduced antegrade Wenckebach point after RF ablation.
- Post-CNA atropine and tilt tests showed preserved conduction and vasodepressor responses, respectively.
- No syncope recurrence observed during 6-13 months of follow-up, with normal Holter monitoring results.
Conclusions:
- Cardioneuroablation (CNA) shows promise as an alternative to pacemakers for late-onset AVB following AVNRT ablation.
- Targeting the inferior paraseptal ganglionated plexus (IPSGP) may be critical for successful outcomes.
- Larger studies are warranted to confirm long-term efficacy and optimal techniques for CNA in this population.
Related Concept Videos
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers


